Abstract

Apolipoprotein E (apoE) plays a key role in the receptor-mediated uptake of lipoproteins by the liver and therefore in regulating plasma levels of lipoproteins. ApoE may also facilitate hepatic secretion of very low density lipoprotein (VLDL) triglyceride (TG). We directly tested the hypothesis that reconstitution of hepatic apoE expression in adult apoE-deficient mice by gene transfer would acutely enhance VLDL-TG production and directly compared the three major human apoE isoforms using this approach. Second generation recombinant adenoviruses encoding the three major isoforms of human apoE (E2, E3, and E4) or a control virus were injected intravenously into apoE-deficient mice, resulting in acute expression of the apoE isoforms in the liver. Despite the expected decreases in total and VLDL cholesterol levels, apoE expression was associated with increased total and VLDL triglyceride levels (E2 > E4 > E3). The increase in TG levels significantly correlated with plasma apoE concentrations. In order to determine whether acute apoE expression influenced the rate of VLDL-TG production, additional experiments were performed. Three days after injection of adenoviruses, Triton WR1339 was injected to block lipolysis of TG-rich lipoproteins and VLDL-TG production rates were determined. Mice injected with control adenovirus had a mean VLDL-TG production rate of 74 ± 7 μmol/h/kg. In contrast, VLDL-TG production rates in apoE-expressing mice were 363 ± 162 μmol/h/kg, 286 ± 175 μmol/h/kg, and 300 ± 84 μmol/h/kg for apoE2, apoE3, and apoE4, respectively. The VLDL-TG production rates in apoE-expressing mice were all significantly greater than in control mice but were not significantly different from each other. In summary, acute expression of all three human apoE isoforms in livers of apoE-deficient mice markedly increased VLDL-TG production to a similar degree, consistent with the concept that apoE plays an important role in facilitating hepatic VLDL-TG production in an isoform-independent manner. —Tsukamoto, K., C. Maugeais, J. M. Glick, and D. J. Rader. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.

Highlights

  • Apolipoprotein E plays a key role in the receptor-mediated uptake of lipoproteins by the liver and in regulating plasma levels of lipoproteins

  • In order to determine whether hepatic Apolipoprotein E (apoE) expression increased triglycerides by increasing the rate of hepatic very low density lipoprotein (VLDL) TG secretion, we utilized Triton WR1339 to acutely inhibit the lipolysis of TG-rich lipoproteins

  • Plasma levels of triglycerides are important determinants of cardiovascular risk [8, 9] and the rate of hepatic VLDL triglyceride production is an important determinant of plasma triglyceride levels

Read more

Summary

Introduction

Apolipoprotein E (apoE) plays a key role in the receptor-mediated uptake of lipoproteins by the liver and in regulating plasma levels of lipoproteins. Expression of apoE2, apoE3, and apoE4 each resulted in a Tsukamoto et al Secretion of VLDL-TG in apoE-deficient mice 255 marked acute reduction in plasma total cholesterol levels, with the effect of apoE2 somewhat less than that of apoE3 and apoE4.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.